979 related articles for article (PubMed ID: 31325434)
1. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
2. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
3. The association between microRNA-21 and hypertension-induced cardiac remodeling.
Watanabe K; Narumi T; Watanabe T; Otaki Y; Takahashi T; Aono T; Goto J; Toshima T; Sugai T; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Watanabe M
PLoS One; 2020; 15(2):e0226053. PubMed ID: 32040481
[TBL] [Abstract][Full Text] [Related]
4. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
7. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-β1.
Zhang X; Zhang MC; Wang CT
Biochem Biophys Res Commun; 2018 Nov; 506(1):137-144. PubMed ID: 30340835
[TBL] [Abstract][Full Text] [Related]
8. Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.
Khan SA; Dong H; Joyce J; Sasaki T; Chu ML; Tsuda T
Lab Invest; 2016 Jul; 96(7):773-83. PubMed ID: 27111286
[TBL] [Abstract][Full Text] [Related]
9. Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor β1 (TGF-β1) pathway.
Li Y; Yu QH; Chu Y; Wu WM; Song JX; Zhu XB; Wang Q
Biochem Biophys Res Commun; 2018 May; 499(2):128-135. PubMed ID: 29501491
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
11. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
Zhao L; Mi Y; Guan H; Xu Y; Mei Y
Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788
[TBL] [Abstract][Full Text] [Related]
12. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
13. Regulation of epithelial mesenchymal transition by the renin-angiotensin system: a role for klotho in renal tubular epithelial cells.
Yang Z; Zhan YW; Huang YY; Huang W; Zhan F; Lin SD
J Biol Regul Homeost Agents; 2020; 34(1):57-67. PubMed ID: 32466632
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
15. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
Zhang Y; Shang Z; Liu A
Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
Lyu H; Li X; Wu Q; Hao L
J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175
[TBL] [Abstract][Full Text] [Related]
20. LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target.
Gu Y; Zhang S; Chen X; Li Y; Liu Y
J Ethnopharmacol; 2022 Jun; 291():115156. PubMed ID: 35245628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]